Developing shorter and more effective oral treatments for lung infections caused by Mycobacterium abscessus
Shorter and more effective oral regimens for M. abscessus pulmonary disease
['FUNDING_R01'] · HACKENSACK UNIVERSITY MEDICAL CENTER · NIH-11133092
This study is looking for new pill-based treatments for people with lung infections caused by a tough bacteria called Mycobacterium abscessus, aiming to make it easier and more comfortable for patients to get better without needing IVs.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | HACKENSACK UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (HACKENSACK, UNITED STATES) |
| Trial ID | NIH-11133092 on ClinicalTrials.gov |
What this research studies
This research focuses on finding new oral treatment regimens for patients suffering from pulmonary disease caused by Mycobacterium abscessus, a type of bacteria that is becoming increasingly resistant to existing antibiotics. The approach involves testing combinations of FDA-approved drugs and new candidates to create effective treatment plans that can be taken by mouth, reducing the need for lengthy and uncomfortable intravenous therapies. The research aims to identify regimens that can quickly reduce the bacterial load in patients, especially those with weakened immune systems, by using a combination of bactericidal and bacteriostatic agents. The effectiveness of these regimens will be evaluated through laboratory models before moving to clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pulmonary disease caused by Mycobacterium abscessus, particularly those who have not responded well to existing treatments.
Not a fit: Patients with pulmonary infections caused by other types of bacteria or those who do not have Mycobacterium abscessus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and shorter treatment options for patients with Mycobacterium abscessus pulmonary disease.
How similar studies have performed: Previous research has shown promise in developing effective treatments for similar bacterial infections, but this specific approach is novel and untested.
Where this research is happening
HACKENSACK, UNITED STATES
- HACKENSACK UNIVERSITY MEDICAL CENTER — HACKENSACK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DICK, THOMAS — HACKENSACK UNIVERSITY MEDICAL CENTER
- Study coordinator: DICK, THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.